Enhanced Prevalence of Plasmatic Soluble MHC Class I Chain-Related Molecule in Vascular Pregnancy Diseases
Table 1
Characteristics of study population.
Normal pregnancies
Vascular pregnancy diseases
Nonvascular IUGR
value
Number of patients
63
81
25
Age (yrs, mean ± sd)
ns
Gestation ()
3 [1–9]
2 [0–7]
2 [0–6]
ns
Parity ()
1 [0–5]
0 [0–4]
0 [0–3]
ns
Body mass index (kg/cm2)
23 [17–48]
23.1 [16.3–37.2]
23 [18–37]
ns
Systolic blood pressure (mmHg)
12 [10–13]
14 [10–22]
12 [10–13]
Diastolic blood pressure (mmHg)
7 [5–8.3]
8.7 [6–12]
7 [5.5–8.5]
Uterine height (cm)
32 [29–38]
26 [15–36]
26 [15–36]
Term at sampling (weeks of gestation)
31.7 [15.3–41]
30 [17–41]
30 [17–41]
ns
Term at delivery (weeks of gestation)
40.3 [35–42]
32.3 [17–41.1]
32 [22–41]
Baby weight at birth (g)
3300 [2640–4680]
1330 [80–3410]
1745 [400–2500]
Comparison between groups was performed with nonparametric Kruskal-Wallis test followed by the Dunn posttest. Values indicate median [25–75 interquartile ranges]. between vascular pregnancy diseases and other groups. between normal pregnancies and other groups.
